Edition:
United Kingdom

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

18.16USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$18.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
881,039
52-wk High
$41.20
52-wk Low
$14.52

Select another date:

Fri, May 4 2018

BRIEF-Acadia Pharmaceuticals Q1 Loss Per Share $0.44

* ACADIA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Acadia Pharmaceuticals Says CEO Stephen Davis's FY 2017 Total Compensation Was $15.2 Mln

* ACADIA PHARMACEUTICALS SAYS CEO STEPHEN DAVIS'S FY 2017 TOTAL COMPENSATION WAS $15.2 MILLION, INCLUDING $13.9 MILLION IN OPTION AWARDS - SEC FILING Source : https://bit.ly/2ra1j3J Further company coverage: (Reuters.Briefs@thomsonreuters.com)

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON, April 25 The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

BRIEF-Acadia Pharma Q4 Loss Per Share $0.55

* ACADIA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Select another date: